Jeremy Weate is the CEO of the Vancouver-based Universal Ibogaine, which plans to go public on the Toronto Stock Exchange shortly. Universal Ibogaine will take ibogaine through clinical trials for opioid use disorder in Canada, with a view to multi-country phase 3 trials. The company will launch ibogaine assisted therapy clinics in North America and subsequently globally this decade under the Clear Sky Recovery brand, beginning with a retreat centre in the Bahamas in Q1 2021.